Eosinophil Dynamics May Help Differentiate Immune-Related From TKI-Related Adverse Events During IO-TKI Therapy for Metastatic Renal Cell Carcinoma: A Multicenter Retrospective Study.
Tomita M, Tasaki Y, Hamamoto S, Osawa T, Yamashita S, Matsumoto R, Ikoma H, Kawase K, Mimura Y, Sugiyama Y, Yasui T, Furukawa-Hibi Y
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.